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Every year, 135 million newborns enter the world, each arriving naked and apparently equal. Yet, their chances of 
surviving and thriving vary dramatically depending on which 
world these babies are born into—ranging from high-income 
countries with universal neonatal intensive care to the world 
of home births without midwives, medical supplies, or health 
system support (Figure 1).
This supplement includes six research articles presenting the 
first systematic estimates of impairment after neonatal mor-
bidity, bringing together the work of almost 50 authors rep-
resenting 35 institutions from 12 countries, from more than a 
thousand different data inputs. We summarize global estimates 
of the incidence of impairments in the year 2010 as a result of 
four major neonatal conditions: preterm birth (including sepa-
rate estimates of visual impairment due to retinopathy of pre-
maturity), intrapartum-associated neonatal encephalopathy 
(sometimes referred to as “birth asphyxia”), severe neonatal 
infections, and hyperbilirubinemia (seen clinically as jaun-
dice) (1–5).
Where you are born strongly affects your outcome, and 
you may be born into four very different worlds. First, 11 
million neonates are born in high-income countries where 
intensive care is universally available, and stillbirth and 
neonatal mortality rates are very low (less than 5 per 1,000 
births), despite attempts to rescue even extremely low-gesta-
tional-age newborns. Survival is now at 80% for those born 
at 25 wk gestational age, with disability risk very low for 
infants born beyond this threshold (3). Yet, even between 
and within high-income countries, the risk of death and dis-
ability varies.
Second, for 34 million births in middle-income countries, 
the majority of births are in hospitals, but access to intensive 
care is not universal, and there is less assurance for quality 
of care through detailed protocols, e.g., for safe oxygen use. 
Although neonatal mortality rates have been dramatically 
reduced in many middle-income countries, with more than 50 
countries halving their neonatal mortality rates in the past 2 
decades (6), the disability rates have increased during this same 
time period, including in moderately preterm babies with pre-
ventable disabilities (3,4). Of 32,000 estimated cases of visual 
impairment due to retinopathy of prematurity worldwide each 
year, 65% are in middle-income regions, with almost none 
identified in Africa outside South Africa, given few survivors 
at lower gestational age in these regions, and few being identi-
fied in high-income regions, given more investment in preven-
tion and eye health management for preterm survivors (2).
In low-income countries, for 40 million births in facilities, 
let alone the 50 million home births (the fourth and most 
invisible world), the vast majority of the burden of disease is 
attributable to deaths rather than to disability; yet here too, 
these are mainly preventable. More than three quarters of 
the world’s 2.9 million neonatal deaths occur in sub-Saharan 
Africa and South Asia, mainly among babies born beyond 
32 wk gestational age, who are dying needlessly, e.g., due to 
infections and yet are not receiving antibiotics (7). These 
global numbers do not include 2.6 million third-trimester 
stillbirths (8), an estimated 1.2 million of who die during 
labor (9). Progress in reducing neonatal mortality (1.8% per 
year) is lagging behind that for maternal deaths (4.2% per 
year) and postneonatal deaths (2.3% per year) (6). Reducing 
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neonatal deaths is increasingly recognized as a public health 
priority in countries largely because of the impact that these 
deaths have on our potential to achieve the Millennium 
Development Goal 4 (10,11). Now, with 44% of all under-
five deaths occurring in the first month of life (the neonatal 
period), reducing neonatal deaths is rising to the top of the 
child survival agenda (7,12).
The Global Burden of Disease estimates that of all global 
disability-adjusted life years in 2010, almost 1 in 10 was due 
to neonatal conditions, and of this, 95% were estimated to 
be due to neonatal deaths rather than subsequent disability 
(13,14). This burden is more than three times that of HIV, 
more than all cancers, similar to all cardiovascular condi-
tions, and still remains barely mentioned in global health 
agendas.
As the focus shifts beyond 2015 to the post–Millennium 
Development Goal era, more recognition is being given to 
disability-free survival, human capital, and sustainable devel-
opment (15). Although neonatal deaths are just beginning to 
receive attention (16), neonatal morbidity and its long-term 
impact on health, disability, and human capital have, to date, 
received almost no attention in many settings and are increas-
ingly important issues for individuals, families, and nations. 
This supplement removes the myth that saving newborn lives 
comes at the expense of an inevitable generation of disabled 
survivors. With basic newborn care, those now surviving 
are not severely disabled—surviving with severe disability is 
seen primarily among those who received neonatal intensive 
care, especially sustained ventilation. Yet, even this disability 
after intensive care is not inevitable, as seen by the doubling 
of impairment risk for preterm babies of 28- to 32-wk gesta-
tion in middle-income countries compared with the risk for 
babies in high-income countries. Higher disability risk is more 
likely with lower-quality intensive care or in the national start-
up phase for provision of intensive care; this can and must be 
reduced over time.
This series of articles also features new analyses shedding 
new light on the observation that boys are at increased mor-
tality risk in the neonatal period. We show that this risk for 
boys is driven by an increased risk for preterm birth and, given 
preterm birth, an excessive risk of death and disability in boys. 
In addition, boys have a higher incidence of neonatal sepsis 
and neonatal encephalopathy (4,5). These findings point out 
the need for more sex-specific global data to inform research 
and policy agendas, in addition to the need for more attention 
toward excess termination in utero for girls.
Figure 1. The four worlds into which 135 million newborns are born each year. Republished with permission from ref. 17.
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Our estimates are constrained by the data available, but this 
is the best attempt yet to combine all the available data and to 
map the size of the problem of neonatal morbidity. Current 
estimates are likely to underestimate the true global burden of 
the range of impairments and disabilities attributable to neo-
natal conditions because we did not cover all outcomes, e.g., 
behavioral conditions. Data gaps were greatest for the poorest 
countries, but worse for conditions that are now rare in rich 
countries, such as intrapartum complications and neonatal 
infections, in contrast with preterm birth, which is common, 
notably in the United States. Shockingly, there are almost no 
national data on neonatal hyperbilirubinemia, apart from 
Denmark and Canada, forcing the use of historical data from 
more than half a century ago (1). We observed a waterfall 
effect with usable data being fewer and fewer at each step 
from incidence and case fatality rate to impairment rates, and 
finally, very few cohort studies report on long-term survival 
of children with disabilities, even in high-income countries. 
The lack of usage of consistent definitions meant that valuable 
studies could not be used. Child development outcomes and 
disability are especially variable in measurement and also in 
timing of assessments. Improved estimates will require better 
data, from the poorest countries, counting birth and develop-
ment outcomes and using consistent definitions.
We hope that this supplement will engage the pediatric, 
obstetric, and public health communities, partnering with 
parents, to strengthen policies and programs to prevent and 
manage these key causes of neonatal mortality and subsequent 
disability. Better data and better use of existing data are foun-
dational. Countries, especially middle-income countries with 
increasing intensive care services, urgently need to improve 
quality of care, and the quality of follow-up data on child 
development, developing services for those with impairment 
(18). Neonatal conditions result in social and economic loss 
to families and nations. Investing in care of every woman and 
every newborn will reduce both deaths and disabilities.
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